SUMMARY Intravenous methylprednisolone pulse therapy in a reduced dose of 10 mg/kg on three consecutive days was successfully used in the treatment of a 9 year old girl with acute cerebral lupus in coma. It is recommended for further evaluation in children with severe primary central nervous system (CNS) disease.
essential role of steroids in severe SLE is undoubted, but when used alone in children oral prednisolone in high dosage is effective in only half of those with severe CNS disease. The combination of steroid and cytotoxic therapy has appeared to be more effective, and intravenous steroid pulse therapy has also been employed.2 Intravenous methylprednisolone (IV MP) in five daily pulses of 30 mg/kg is well established in the management of renal SLE3 and has been recommended for use in non-renal SLE uncontrolled by other means,4 5 
Discussion
In CNS lupus, convulsions, cerebral dysfunction, neuropathy, strokes, and chorea may occur together or in isolation and are often heralded by psychiatric disturbance.
We have no evidence that this patient's coma was not primarily due to cerebral lupus. There is no entirely satisfactory laboratory test of CNS involvement so diagnosis is essentially clinical and relies on the exclusion of cerebral dysfunction secondary to other disorders, lupus nephritis, and drug therapy. Liver dysfunction and prolonged PT and P1T can arise as an early complication of aspirin therapy,6 and when this is stopped there is a characteristically rapid return to normal values as seen in this patient. It is improbable that her clotting defect was primarily due to SLE or her coma the result of hepatotoxicity.
In this patient IV MP in a bolus of 10 mg/kg on three consecutive davs was clinically effective and improved levels of ds-DNA antibody and C3 complement. It 
